Home › Funds › Morgan Stanley › Morgan Stanley Europe Opportunity Fund Inc.
Fund family: Morgan Stanley · Filed by Morgan Stanley Europe Opportunity Fund Inc. (CIK 860720) · SEC series S000002387
Share classes and tickers: EUGAX (C000006316), EUGCX (C000006318), EUGDX (C000006319), MSEEX (C000155977)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 334 with, 0 against, 0 abstentions (not counted as with management); 9 items carried no recommendation. Shareholder proposals: 3 FOR, 1 AGAINST, 5 abstained, by the filing’s own vote-source field.
The same two figures as Morgan Stanley’s manager page (139,958 ballot items across 61 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Morgan Stanley | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 99.3% | 272 | 86.0% | 111,214 |
| Backed environmental and social shareholder proposals at US companies | n/a | 0 | 27.9% | 1,130 |
Each ballot item this fund voted is set against the votes of the other Morgan Stanley funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Morgan Stanley funds on 18 items (5.9% of the 306 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Morgan Stanley funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| London Stock Exchange Group plc | 2026-04-23 | Authorise the Company to Call General Meeting with Two Weeks' Notice | For | AGAINST — 5 of 6 Morgan Stanley funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Approve Auditors' Special Report on Related-Party Transactions Mentioning the Absence of New Transactions | For | AGAINST — 5 of 8 Morgan Stanley funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Approve Compensation Report of Corporate Officers | For | AGAINST — 5 of 8 Morgan Stanley funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Approve Compensation of Bernard Arnault, Chairman and CEO | For | AGAINST — 5 of 8 Morgan Stanley funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Approve Remuneration Policy of Chairman and CEO | For | AGAINST — 5 of 8 Morgan Stanley funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Reelect Laurent Mignon as Director | For | AGAINST — 5 of 8 Morgan Stanley funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Reelect Marie-Josee Kravis as Director | For | AGAINST — 5 of 8 Morgan Stanley funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Reelect Natacha Valla as Director | For | AGAINST — 5 of 8 Morgan Stanley funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Renew Appointment of Diego Della Valle as Censor | For | AGAINST — 5 of 8 Morgan Stanley funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Renew Appointment of Lord Powell of Bayswater as Censor | For | AGAINST — 5 of 8 Morgan Stanley funds | For | — |
| Novo Nordisk A/S | 2025-11-14 | Shareholder Elect Britt Meelby Jensen as New Director | Abstain | FOR — 3 of 4 Morgan Stanley funds | — | — |
| Novo Nordisk A/S | 2025-11-14 | Shareholder Elect Cees de Jong (Vice Chair) as New Director | Abstain | FOR — 3 of 4 Morgan Stanley funds | — | — |
| Novo Nordisk A/S | 2025-11-14 | Shareholder Elect Lars Rebien Sorensen (Chair) as New Director | Abstain | FOR — 3 of 4 Morgan Stanley funds | — | — |
| Novo Nordisk A/S | 2025-11-14 | Shareholder Elect Mikael Dolsten as New Director | Abstain | FOR — 3 of 4 Morgan Stanley funds | — | — |
| Novo Nordisk A/S | 2025-11-14 | Shareholder Elect Stephan Engels as New Director | Abstain | FOR — 3 of 4 Morgan Stanley funds | — | — |
| London Stock Exchange Group plc | 2026-04-23 | Approve Remuneration Report | For | AGAINST — 4 of 6 Morgan Stanley funds | For | — |
| On Holding AG | 2026-05-28 | Transact Other Business (Voting) | For | AGAINST — 4 of 7 Morgan Stanley funds | For | — |
| Wise Plc | 2025-09-25 | Approve Remuneration Report | For | AGAINST — 3 of 5 Morgan Stanley funds | For | — |
Download all 18 differences (CSV)
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 143 | 0 |
| Compensation | 63 | 0 |
| Corporate Governance | 61 | 0 |
| Capital Structure | 52 | 0 |
| Audit-related | 19 | 0 |
| Extraordinary Transactions | 3 | 0 |
| Other Social Issues | 2 | 0 |
343 ballot items at 20 meetings in 2025-2026. Download all votes (CSV)
In the 2025-2026 proxy season, Morgan Stanley Europe Opportunity Fund Inc. (EUGAX) voted at 20 shareholder meetings of 17 companies, on 343 ballot items in all. Where management made a recommendation, the fund followed it on 100.0% of the items and voted against it 0 times. It voted on 9 shareholder proposals. It voted FOR the board's own proposals more often than Morgan Stanley's funds as a whole (99.3% against 86.0%). It voted differently from most Morgan Stanley funds on 18 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Morgan Stanley’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.